These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Commentary: Addressing corporate influence through ethical guidelines. Greenland S Int J Epidemiol; 2008 Feb; 37(1):57-9; discussion 65-8. PubMed ID: 18245052 [No Abstract] [Full Text] [Related]
43. Medical partisans? Why doctors need conflicting interests. Healy D Aust N Z J Psychiatry; 2012 Aug; 46(8):704-7. PubMed ID: 22848058 [No Abstract] [Full Text] [Related]
44. Ethics of doctors during difficult period. Phaosavasdi S; Taneepanichskul S; Tannirandorn Y; Karnjanapitak A; Pruksapong C; Kullavanijaya P J Med Assoc Thai; 2003 Jan; 86(1):93-6. PubMed ID: 12678144 [No Abstract] [Full Text] [Related]
45. Disclosure of potential conflicts of interest in dermatological guidelines in Germany - an analysis - status quo and quo vadis. Rosumeck S; Sporbeck B; Rzany B; Nast A J Dtsch Dermatol Ges; 2011 Apr; 9(4):297-304. PubMed ID: 21439013 [TBL] [Abstract][Full Text] [Related]
46. Homeopathy, a "helpful placebo" or an unethical intervention? Ernst E Trends Pharmacol Sci; 2010 Jan; 31(1):1. PubMed ID: 19963285 [No Abstract] [Full Text] [Related]
47. Conflict of interest: in the eye of the beholder? Chabner BA Oncologist; 2008 Mar; 13(3):212-3. PubMed ID: 18378530 [No Abstract] [Full Text] [Related]
48. Why self-regulation does not work: resolving prescription corruption caused by excessive gift-giving by pharmaceutical manufacturers. Mehta RS Food Drug Law J; 2008; 63(4):799-821. PubMed ID: 19593922 [No Abstract] [Full Text] [Related]
49. How can empirical ethics improve medical practice? Førde R Camb Q Healthc Ethics; 2012 Oct; 21(4):517-26. PubMed ID: 22828045 [No Abstract] [Full Text] [Related]
50. Leveraging the synergy between industry and academia. Bradley WG J Am Coll Radiol; 2005 Nov; 2(11):879-82. PubMed ID: 17411959 [No Abstract] [Full Text] [Related]
51. Conflict of interest in medical research and development. Ward S Semin Perioper Nurs; 1993 Jul; 2(3):197-201. PubMed ID: 8044171 [TBL] [Abstract][Full Text] [Related]
53. Neglected ethical dimensions of the professional liability crisis. Chervenak FA; McCullough LB Am J Obstet Gynecol; 2004 May; 190(5):1198-200. PubMed ID: 15167818 [TBL] [Abstract][Full Text] [Related]
54. Falling into line: the impact of utilization review hassles on physicians' adherence to insurance contracts. Weiner SJ; VanGeest JB; Wynia MK; Cummins DS; Wilson IB J Clin Ethics; 2004; 15(2):139-48. PubMed ID: 15481165 [No Abstract] [Full Text] [Related]
55. Medicine and the pharmaceutical industry: a call to action. Stiles MM; Barrett B Am Fam Physician; 2007 May; 75(10):1447, 1451; discussion 1451. PubMed ID: 17555137 [No Abstract] [Full Text] [Related]
56. Nonclinical use of online social networking sites: new and old challenges to medical professionalism. Thompson LA; Black EW J Clin Ethics; 2011; 22(2):179-82. PubMed ID: 21837891 [TBL] [Abstract][Full Text] [Related]
57. [Physicians and alternative treatment]. Markestad T Tidsskr Nor Laegeforen; 2012 Nov; 132(21):2409-10. PubMed ID: 23160595 [No Abstract] [Full Text] [Related]
58. Justifiable deception in everyday practice. Wolf BL; Johnson A; Payne K J Allergy Clin Immunol; 2010 Apr; 125(4):939-41. PubMed ID: 20226504 [No Abstract] [Full Text] [Related]
59. Sample pharmaceuticals. Laughlin PA Am Fam Physician; 1992 May; 45(5):2007-8. PubMed ID: 1575100 [No Abstract] [Full Text] [Related]
60. Introduction: conflicting interest in medicine: stories by physicians on how financing affects their work. DuBois JM Narrat Inq Bioeth; 2011; 1(2):65-6. PubMed ID: 24406642 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]